ABCD Trial Could Expand ICD Market If TWA Flies As A Stand-Alone Test
This article was originally published in The Gray Sheet
Executive Summary
The Alternans Before Cardioverter-Defibrillator (ABCD) trial could be the basis for a stand-alone indication for Cambridge Heart's microwave T-wave alternans (TWA) test, according to the company.